Sign In
Buy CRSP
$46.99
-0.790 (-1.65%)
At Close: Jul 20, 2026
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Monday, 21'st Apr 2025
CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade
07:05pm, Thursday, 17'th Apr 2025
The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $37.77, representing a -0.03% change from its previous close.
3 Magnificent Stocks That Could Double or More by 2030
02:45pm, Saturday, 12'th Apr 2025
When the stock market is as turbulent as it is these days, it's easy to forget the times when things are decidedly more cheery. However, sell-offs present great opportunities to buy stocks with signif
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
03:45am, Friday, 11'th Apr 2025
Vertex Pharmaceuticals (VRTX -1.39%) is a great example of biotech success. The company has built a cystic fibrosis (CF) empire, bringing in billions of dollars in revenue annually, and now is even ex
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
10:00am, Wednesday, 09'th Apr 2025
CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference (Transcript)
03:29pm, Tuesday, 08'th Apr 2025
CRISPR Therapeutics AG (NASDAQ:CRSP ) Annual Needham Virtual Healthcare Conference Call April 8, 2025 12:45 PM ET Company Participants Sam Kulkarni - Chief Executive Officer Conference Call Participan
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
08:09am, Monday, 07'th Apr 2025
As biotech investors know, companies in the industry can sometimes earn significant returns in relatively short periods, like a year, thanks to excellent clinical or regulatory progress. And based on
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
07:30am, Monday, 07'th Apr 2025
It's shaping up to be another rocky week of trading, and the volatility will probably keep Cathie Wood busy. The co-founder, CEO, and ace stock picker for Ark Invest tends to be active when the market
Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March
09:30am, Thursday, 03'rd Apr 2025
Shares of early-stage biotech stocks, including Biohaven (BHVN -6.50%), Recursion Pharmaceuticals (RXRX -4.92%), and CRISPR Therapeutics (CRSP -2.05%), plunged in March, with the stocks down 35.3%, 29
CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
08:00am, Thursday, 03'rd Apr 2025
ZUG, Switzerland and BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious dise
Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr.
08:25am, Tuesday, 01'st Apr 2025
The decline in biotech stocks comes after FDA official Peter Marks' resignation, citing irreconcilable differences with the new HHS Secretary.
Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today
03:25pm, Monday, 31'st Mar 2025
Shares of biotechnology stocks such as Recursion Pharmaceuticals (RXRX -8.18%), Summit Therapeutics (SMMT -4.28%), and CRISPR Therapeutics AG (CRSP -8.06%) plunged on Monday, down 9.4%, 5.6%, and 9.2%
Promising Genomics & Synthetic Biology Stocks to Consider in 2025
10:41am, Friday, 28'th Mar 2025
Investors interested in the Genomics and Synthetic Biology theme should consider these stocks: Twist Bioscience Corporation, Wave Life Sciences, and CRISPR Therapeutics AG.
CRISPR Therapeutics Announces Transition of Chief Operating Officer
04:01pm, Wednesday, 26'th Mar 2025
ZUG, Switzerland and BOSTON, March 26, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious dis
CRISPR Therapeutics Set To Reach Previous Heights
11:03am, Tuesday, 25'th Mar 2025
Despite a lackluster launch, CASGEVY has significant potential in international markets, bolstering CRISPR's long-term value. Upcoming milestones and updates on CRISPR Therapeutics is currently sittin
